Tolmetin | hsa00010 | Glycolysis / Gluconeogenesis | 1.52E-02 | 2 | P04075, P14618 | ALDOA, PKM2 | More | |
Tolmetin | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
Tolmetin | hsa00071 | Fatty acid degradation | 4.66E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | |
Tolmetin | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | |
Tolmetin | hsa00500 | Starch and sucrose metabolism | 2.61E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
Tolmetin | hsa00510 | N-Glycan biosynthesis | 1.00E-02 | 2 | O94777, Q9BVK2 | DPM2, ALG8 | More | |
Tolmetin | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | |
Tolmetin | hsa00561 | Glycerolipid metabolism | 2.03E-03 | 2 | P14550, Q86XP1 | AKR1A1, DGKH | More | |
Tolmetin | hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 3.47E-03 | 2 | O94777, Q14442 | DPM2, PIGH | More | |
Tolmetin | hsa00565 | Ether lipid metabolism | 5.94E-07 | 2 | Q9Y6K0, Q8N661 | CEPT1, TMEM86B | More | |
Tolmetin | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
Tolmetin | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
Tolmetin | hsa00600 | Sphingolipid metabolism | 4.47E-02 | 2 | Q96G23, Q86VZ5 | LASS2, SGMS1 | More | |
Tolmetin | hsa00970 | Aminoacyl-tRNA biosynthesis | 6.28E-04 | 3 | O95363, P14868, Q15046 | FARS2, DARS, KARS | More | |
Tolmetin | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-05 | 4 | Q16772, P78417, P09211, P11712 | GSTA3, GSTO1, GSTP1, CYP2C9 | More | |
Tolmetin | hsa00982 | Drug metabolism - cytochrome P450 | 1.77E-04 | 4 | P11712, Q16772, P09211, P78417 | CYP2C9, GSTA3, GSTP1, GSTO1 | More | |
Tolmetin | hsa00983 | Drug metabolism - other enzymes | 1.72E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | |
Tolmetin | hsa01100 | Metabolic pathways | 2.60E-06 | 26 | Q9Y234, P35790, Q16772, P09211, Q9UJ14, P30041, Q6ZQY3, Q02153, P20839, P40926, O94777, Q7KZN9, Q9Y6K0, P15121, Q86XP1, P14550, Q9UHK6, Q86VZ5, Q96G23, Q9BVK2, Q14442, P37837, Q9BQB6, Q06055, Q99437, Q9NVH6 | LIPT1, CHKA, GSTA3, GSTP1, GGTL3, PRDX6, GADL1, GUCY1B3, IMPDH1, MDH2, DPM2, COX15, CEPT1, AKR1B1, DGKH, AKR1A1, AMACR, SGMS1, LASS2, ALG8, PIGH, TALDO1, VKORC1, ATP5G2, ATP6V0B, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.738 | P10145 | IL8 | Interleukin-8 | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.766 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P35790 | CHKA | Choline kinase alpha | -0.717 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.793 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P09211 | GSTP1 | Glutathione S-transferase P | 0.712 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | 0.748 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.75 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q6ZQY3 | GADL1 | Acidic amino acid decarboxylase GADL1 | 0.743 | P10145 | IL8 | Interleukin-8 | Q6ZQY3 | GADL1 | Acidic amino acid decarboxylase GADL1 | 0.753 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | -0.741 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 0.788 | P10145 | IL8 | Interleukin-8 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 0.764 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | 0.81 | P10145 | IL8 | Interleukin-8 | O94777 | DPM2 | Dolichol phosphate-mannose biosynthesis regulatory protein | 0.757 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q7KZN9 | COX15 | Cytochrome c oxidase assembly protein COX15 homolog | 0.764 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.748 | P10145 | IL8 | Interleukin-8 | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.758 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 1 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q86XP1 | DGKH | Diacylglycerol kinase eta | -0.792 | P10145 | IL8 | Interleukin-8 | Q86XP1 | DGKH | Diacylglycerol kinase eta | -0.805 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | P14550 | AKR1A1 | Aldo-keto reductase family 1 member A1 | 0.733 | P10145 | IL8 | Interleukin-8 | P14550 | AKR1A1 | Aldo-keto reductase family 1 member A1 | 0.723 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.768 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.704 | P10145 | IL8 | Interleukin-8 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.744 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.78 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.736 | P10145 | IL8 | Interleukin-8 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.758 | P10145 | IL8 | Interleukin-8 | Q96G23 | LASS2 | Ceramide synthase 2 | -0.796 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q9BVK2 | ALG8 | Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase | -0.754 | P10145 | IL8 | Interleukin-8 | Q9BVK2 | ALG8 | Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase | -0.844 | P10145 | IL8 | Interleukin-8 | Q14442 | PIGH | Phosphatidylinositol N-acetylglucosaminyltransferase subunit H | -0.752 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | P37837 | TALDO1 | Transaldolase | 0.746 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9BQB6 | VKORC1 | Vitamin K epoxide reductase complex subunit 1 | 0.731 | P10145 | IL8 | Interleukin-8 | Q06055 | ATP5G2 | ATP synthase F(0) complex subunit C2, mitochondrial | -0.753 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q99437 | ATP6V0B | V-type proton ATPase 21 kDa proteolipid subunit c'' | 0.72 | P10145 | IL8 | Interleukin-8 | Q99437 | ATP6V0B | V-type proton ATPase 21 kDa proteolipid subunit c'' | 0.732 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | -0.799 | P10145 | IL8 | Interleukin-8 | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | -0.73 |
|
Tolmetin | hsa01200 | Carbon metabolism | 3.16E-02 | 2 | P04075, P14618 | ALDOA, PKM2 | More | |
Tolmetin | hsa01230 | Biosynthesis of amino acids | 1.26E-02 | 2 | P14618, P04075 | PKM2, ALDOA | More | |
Tolmetin | hsa01240 | Biosynthesis of cofactors | 1.26E-02 | 2 | P13716, P14618 | ALAD, PKM2 | More | |
Tolmetin | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | |
Tolmetin | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
Tolmetin | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | |
Tolmetin | hsa03013 | RNA transport | 4.09E-02 | 9 | P52298, Q09161, O14893, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | |
Tolmetin | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | |
Tolmetin | hsa03040 | Spliceosome | 1.28E-05 | 13 | O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | |
Tolmetin | hsa03410 | Base excision repair | 7.59E-03 | 1 | P27695 | APEX1 | More | |
Tolmetin | hsa03460 | Fanconi anemia pathway | 4.83E-02 | 2 | Q9BXW9, P07992 | FANCD2, ERCC1 | More | |
Tolmetin | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04012 | ErbB signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04014 | Ras signaling pathway | 1.13E-02 | 9 | P04049, P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | RAF1, PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | |
Tolmetin | hsa04015 | Rap1 signaling pathway | 5.95E-03 | 9 | P04049, P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | RAF1, EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | |
Tolmetin | hsa04022 | cGMP-PKG signaling pathway | 3.15E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04024 | cAMP signaling pathway | 2.49E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | |
Tolmetin | hsa04062 | Chemokine signaling pathway | 2.48E-04 | 15 | P25024, P25025, P09341, P19875, P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, P04049, Q8WYR1 | CXCR1, CXCR2, CXCL1, CXCL2, FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, RAF1, PIK3R5 | More | |
Tolmetin | hsa04064 | NF-kappa B signaling pathway | 2.50E-07 | 18 | P10415, Q13489, P25963, P51617, O00463, P14778, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q13315, P24522, P09341, P19875, Q06643 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, IL1R1, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, ATM, GADD45A, CXCL1, CXCL2, LTB | More | |
Tolmetin | hsa04066 | HIF-1 signaling pathway | 2.12E-02 | 2 | P04075, Q15389 | ALDOA, ANGPT1 | More | |
Tolmetin | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04070 | Phosphatidylinositol signaling system | 1.53E-02 | 2 | Q86XP1, Q96DU7 | DGKH, ITPKC | More | |
Tolmetin | hsa04071 | Sphingolipid signaling pathway | 1.65E-04 | 8 | P04049, P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415 | RAF1, PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | |
Tolmetin | hsa04072 | Phospholipase D signaling pathway | 2.31E-02 | 6 | P04049, P42338, P43657, P25024, P25025, P19174 | RAF1, PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | |
Tolmetin | hsa04080 | Neuroactive ligand-receptor interaction | 3.44E-04 | 8 | P08311, Q15722, P21453, Q9H228, O00398, P21462, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, ADRB2 | More | |
Tolmetin | hsa04114 | Oocyte meiosis | 1.33E-02 | 4 | P51812, Q02750, P16298, Q17RY0 | RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | |
Tolmetin | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | |
Tolmetin | hsa04140 | Autophagy - animal | 2.95E-02 | 5 | P04049, P22694, Q14643, P10415, Q04759 | RAF1, PRKACB, ITPR1, BCL2, PRKCQ | More | |
Tolmetin | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | |
Tolmetin | hsa04145 | Phagosome | 2.60E-03 | 8 | Q15080, P14598, Q13509, Q13488, P05164, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | |
Tolmetin | hsa04150 | mTOR signaling pathway | 7.74E-03 | 4 | P04049, Q02750, Q9NQL2, P51812 | RAF1, MAP2K1, RRAGD, RPS6KA3 | More | |
Tolmetin | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | |
Tolmetin | hsa04210 | Apoptosis | 2.38E-04 | 12 | Q13315, P10415, Q13489, O76075, P25963, P01375, P24522, Q16548, Q13077, P43234, Q14643, P04049 | ATM, BCL2, BIRC3, DFFB, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, CTSO, ITPR1, RAF1 | More | |
Tolmetin | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | |
Tolmetin | hsa04217 | Necroptosis | 4.42E-04 | 6 | P07900, P15104, P05141, P01584, P0C0S5, Q13557 | HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D | More | |
Tolmetin | hsa04218 | Cellular senescence | 2.49E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04270 | Vascular smooth muscle contraction | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04330 | Notch signaling pathway | 3.09E-02 | 2 | P49768, P78504 | PSEN1, JAG1 | More | |
Tolmetin | hsa04340 | Hedgehog signaling pathway | 3.09E-02 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | |
Tolmetin | hsa04360 | Axon guidance | 1.51E-02 | 7 | P16333, P20827, O95631, P42338, P07332, P04049, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, RAF1, PLCG1 | More | |
Tolmetin | hsa04370 | VEGF signaling pathway | 1.79E-04 | 4 | P16298, Q05397, Q02750, P04049 | PPP3CB, PTK2, MAP2K1, RAF1 | More | |
Tolmetin | hsa04371 | Apelin signaling pathway | 4.16E-03 | 8 | P63218, P50151, Q8WYR1, P04049, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, RAF1, MEF2D, GNA13, SMAD4, SMAD3 | More | |
Tolmetin | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
Tolmetin | hsa04540 | Gap junction | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | |
Tolmetin | hsa04612 | Antigen processing and presentation | 1.93E-03 | 7 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A | More | |
Tolmetin | hsa04613 | Neutrophil extracellular trap formation | 2.88E-06 | 18 | P17252, P04049, O60603, P05164, P08246, Q9UM07, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P20160, P08311, P49913, P21730, P21462 | PRKCA, RAF1, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, CAMP, C5AR1, FPR1 | More | |
Tolmetin | hsa04621 | NOD-like receptor signaling pathway | 3.10E-03 | 11 | Q14643, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ITPR1, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | |
Tolmetin | hsa04625 | C-type lectin receptor signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04630 | JAK-STAT signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | |
Tolmetin | hsa04650 | Natural killer cell mediated cytotoxicity | 9.13E-08 | 16 | P16298, P50591, P19174, P78314, P06239, O60880, P20963, P42338, Q02750, P04049, Q13241, P26718, O14931, O75015, P26717, P26715 | PPP3CB, TNFSF10, PLCG1, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, MAP2K1, RAF1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | |
Tolmetin | hsa04657 | IL-17 signaling pathway | 4.87E-02 | 2 | P07900, P01584 | HSP90AA1, IL1B | More | |
Tolmetin | hsa04658 | Th1 and Th2 cell differentiation | 7.66E-07 | 12 | Q04759, P07766, P20963, P09693, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | |
Tolmetin | hsa04659 | Th17 cell differentiation | 5.84E-06 | 14 | Q04759, P19174, P06239, P14784, P13765, P14778, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | PRKCQ, PLCG1, LCK, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | |
Tolmetin | hsa04660 | T cell receptor signaling pathway | 1.25E-07 | 18 | P01375, P25963, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, P04049, Q16539, P49841 | TNF, NFKBIA, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, RAF1, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P08246 | ELA2 | Neutrophil elastase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.701 | P08246 | ELA2 | Neutrophil elastase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.896 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P08246 | ELA2 | Neutrophil elastase | Q04759 | PRKCQ | Protein kinase C theta type | -0.748 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P08246 | ELA2 | Neutrophil elastase | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | -0.854 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P08246 | ELA2 | Neutrophil elastase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.724 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.716 | P08246 | ELA2 | Neutrophil elastase | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.782 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.746 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.722 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.77 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.722 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.719 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.889 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.861 |
|
Tolmetin | hsa04662 | B cell receptor signaling pathway | 2.42E-03 | 6 | P42338, P60033, P07948, P21854, Q8N149, P04049 | PIK3CB, CD81, LYN, CD72, LILRA2, RAF1 | More | |
Tolmetin | hsa04664 | Fc epsilon RI signaling pathway | 5.86E-03 | 5 | P42338, P07948, P19174, P04049, P09917 | PIK3CB, LYN, PLCG1, RAF1, ALOX5 | More | |
Tolmetin | hsa04666 | Fc gamma R-mediated phagocytosis | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04668 | TNF signaling pathway | 2.59E-02 | 7 | P01375, O00463, Q13489, P25963, P20749, Q13077, P14780 | TNF, TRAF5, BIRC3, NFKBIA, BCL3, TRAF1, MMP9 | More | |
Tolmetin | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | |
Tolmetin | hsa04720 | Long-term potentiation | 2.17E-03 | 4 | P16298, P51812, Q02750, P04049 | PPP3CB, RPS6KA3, MAP2K1, RAF1 | More | |
Tolmetin | hsa04721 | Synaptic vesicle cycle | 3.05E-03 | 2 | Q99437, P43005 | ATP6V0B, SLC1A1 | More | |
Tolmetin | hsa04722 | Neurotrophin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04726 | Serotonergic synapse | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04730 | Long-term depression | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | |
Tolmetin | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04910 | Insulin signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04912 | GnRH signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04914 | Progesterone-mediated oocyte maturation | 5.89E-03 | 4 | Q17RY0, P51812, Q02750, P04049 | CPEB4, RPS6KA3, MAP2K1, RAF1 | More | |
Tolmetin | hsa04915 | Estrogen signaling pathway | 2.99E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04916 | Melanogenesis | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04917 | Prolactin signaling pathway | 6.63E-03 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04919 | Thyroid hormone signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04920 | Adipocytokine signaling pathway | 4.49E-02 | 4 | P25963, P33121, Q04759, P01375 | NFKBIA, ACSL1, PRKCQ, TNF | More | |
Tolmetin | hsa04921 | Oxytocin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | |
Tolmetin | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | |
Tolmetin | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | |
Tolmetin | hsa04926 | Relaxin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.60E-02 | 5 | Q14643, P22694, P23771, P04049, P10415 | ITPR1, PRKACB, GATA3, RAF1, BCL2 | More | |
Tolmetin | hsa04929 | GnRH secretion | 4.98E-03 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04932 | Non-alcoholic fatty liver disease | 9.70E-03 | 4 | P18848, P01584, P13073, O15239 | ATF4, IL1B, COX4I1, NDUFA1 | More | |
Tolmetin | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | |
Tolmetin | hsa04935 | Growth hormone synthesis, secretion and action | 2.16E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
Tolmetin | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | |
Tolmetin | hsa04970 | Salivary secretion | 4.49E-02 | 4 | P22694, Q14643, P17252, P49913 | PRKACB, ITPR1, PRKCA, CAMP | More | |
Tolmetin | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | |
Tolmetin | hsa05012 | Parkinson disease | 2.53E-02 | 5 | O15239, P13073, P05141, P18848, Q13557 | NDUFA1, COX4I1, SLC25A5, ATF4, CAMK2D | More | |
Tolmetin | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | |
Tolmetin | hsa05020 | Prion disease | 3.37E-03 | 7 | P13591, P01584, P11142, O15239, P13073, P18848, P05141 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5 | More | |
Tolmetin | hsa05022 | Pathways of neurodegeneration - multiple diseases | 3.80E-02 | 6 | O15239, P13073, P18848, P05141, P01584, Q13557 | NDUFA1, COX4I1, ATF4, SLC25A5, IL1B, CAMK2D | More | |
Tolmetin | hsa05034 | Alcoholism | 2.78E-04 | 5 | P04049, Q93077, P62807, O60814, P68431 | RAF1, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Tolmetin | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.53E-05 | 7 | Q99437, P09341, P19875, P10145, P19174, P25024, P25025 | ATP6V0B, CXCL1, CXCL2, IL8, PLCG1, CXCR1, CXCR2 | More | |
Tolmetin | hsa05131 | Shigellosis | 3.34E-02 | 11 | P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32 | TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPF | More | |
Tolmetin | hsa05132 | Salmonella infection | 1.81E-02 | 12 | P51617, P25963, P01375, P04049, Q9UJU2, Q13489, P10415, Q96A32, O60603, Q9BQS8, Q13561, Q13509 | IRAK1, NFKBIA, TNF, RAF1, LEF1, BIRC3, BCL2, MYLPF, TLR2, FYCO1, DCTN2, TUBB3 | More | |
Tolmetin | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | |
Tolmetin | hsa05134 | Legionellosis | 6.38E-04 | 6 | P01584, P11215, P68104, P11142, P09341, P19875 | IL1B, ITGAM, EEF1A1, HSPA8, CXCL1, CXCL2 | More | |
Tolmetin | hsa05140 | Leishmaniasis | 1.18E-02 | 7 | P14598, P13765, O60603, P25963, P01375, P51617, Q15080 | NCF1, HLA-DOB, TLR2, NFKBIA, TNF, IRAK1, NCF4 | More | |
Tolmetin | hsa05143 | African trypanosomiasis | 5.67E-04 | 2 | P69905, P68871 | HBA2, HBB | More | |
Tolmetin | hsa05144 | Malaria | 2.03E-04 | 7 | P60033, P69905, P68871, O60603, P35443, P10145, P26718 | CD81, HBA2, HBB, TLR2, THBS4, IL8, KLRK1 | More | |
Tolmetin | hsa05145 | Toxoplasmosis | 3.07E-02 | 7 | P51617, P25963, P01375, P10415, Q13489, P13765, O60603 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, HLA-DOB, TLR2 | More | |
Tolmetin | hsa05146 | Amoebiasis | 2.21E-04 | 8 | P09341, P19875, P14778, P27930, P42338, P11215, P05089, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, PIK3CB, ITGAM, ARG1, ACTN1 | More | |
Tolmetin | hsa05152 | Tuberculosis | 1.41E-02 | 10 | P04049, Q13488, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, P51617 | RAF1, TCIRG1, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, IRAK1 | More | |
Tolmetin | hsa05160 | Hepatitis C | 1.99E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05161 | Hepatitis B | 4.82E-03 | 9 | P17252, P04049, P14780, P25963, P01375, P10415, P51617, O60603, Q14765 | PRKCA, RAF1, MMP9, NFKBIA, TNF, BCL2, IRAK1, TLR2, STAT4 | More | |
Tolmetin | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | |
Tolmetin | hsa05163 | Human cytomegalovirus infection | 4.98E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05164 | Influenza A | 3.65E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.57E-03 | 5 | P62879, P16298, P04049, Q02750, P0CG47 | GNB2, PPP3CB, RAF1, MAP2K1, UBB | More | |
Tolmetin | hsa05170 | Human immunodeficiency virus 1 infection | 7.33E-06 | 19 | P04049, Q02750, P62879, P16298, P01375, Q05397, P17252, O00463, Q14643, P51617, P25963, O60603, Q13315, O95067, P10415, Q13619, Q93034, Q9Y6Q5, P20333 | RAF1, MAP2K1, GNB2, PPP3CB, TNF, PTK2, PRKCA, TRAF5, ITPR1, IRAK1, NFKBIA, TLR2, ATM, CCNB2, BCL2, CUL4A, CUL5, AP1M2, TNFRSF1B | More | |
Tolmetin | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | |
Tolmetin | hsa05200 | Pathways in cancer | 9.46E-03 | 17 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | |
Tolmetin | hsa05202 | Transcriptional misregulation in cancer | 1.31E-06 | 19 | Q92570, Q12778, Q15532, Q13315, O94812, P58340, P10145, P14780, P14923, Q16548, Q13489, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | NR4A3, FOXO1, SS18, ATM, BAIAP3, MLF1, IL8, MMP9, JUP, BCL2A1, BIRC3, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | |
Tolmetin | hsa05203 | Viral carcinogenesis | 6.22E-03 | 5 | Q12933, P42229, Q15283, P62807, O60814 | TRAF2, STAT5A, RASA2, HIST1H2BC, H2BC12 | More | |
Tolmetin | hsa05204 | Chemical carcinogenesis | 1.77E-04 | 4 | Q16772, P09211, P78417, P11712 | GSTA3, GSTP1, GSTO1, CYP2C9 | More | |
Tolmetin | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05206 | MicroRNAs in cancer | 3.15E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05210 | Colorectal cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05211 | Renal cell carcinoma | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05212 | Pancreatic cancer | 8.83E-03 | 5 | P42338, P04049, P84022, Q13485, O75293 | PIK3CB, RAF1, SMAD3, SMAD4, GADD45B | More | |
Tolmetin | hsa05213 | Endometrial cancer | 4.26E-03 | 3 | O15169, Q02750, P04049 | AXIN1, MAP2K1, RAF1 | More | |
Tolmetin | hsa05214 | Glioma | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05218 | Melanoma | 6.63E-03 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05219 | Bladder cancer | 4.98E-03 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05220 | Chronic myeloid leukemia | 3.00E-03 | 6 | Q13547, Q13485, P84022, P42338, P04049, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, RAF1, GADD45B | More | |
Tolmetin | hsa05221 | Acute myeloid leukemia | 8.29E-03 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05222 | Small cell lung cancer | 2.79E-02 | 6 | Q13489, P10415, P25963, Q13077, O00463, P24522 | BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | |
Tolmetin | hsa05223 | Non-small cell lung cancer | 6.63E-03 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05224 | Breast cancer | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05226 | Gastric cancer | 3.26E-03 | 3 | P04049, Q02750, O15169 | RAF1, MAP2K1, AXIN1 | More | |
Tolmetin | hsa05230 | Central carbon metabolism in cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05231 | Choline metabolism in cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Tolmetin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.14E-04 | 10 | P42338, P19174, P07766, P20963, P09693, P06239, P04049, O60603, P10747, Q04759 | PIK3CB, PLCG1, CD3E, CD247, CD3G, LCK, RAF1, TLR2, CD28, PRKCQ | More | |
Tolmetin | hsa05310 | Asthma | 3.88E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | |
Tolmetin | hsa05321 | Inflammatory bowel disease | 6.27E-05 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | |
Tolmetin | hsa05322 | Systemic lupus erythematosus | 2.09E-04 | 12 | P08246, P08311, P09871, P01375, P10747, P13765, Q6FI13, Q93077, P62807, O60814, P68431, P05455 | ELA2, CTSG, C1S, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, SSB | More | |
Tolmetin | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | |
Tolmetin | hsa05332 | Graft-versus-host disease | 1.14E-04 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | |
Tolmetin | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
Tolmetin | hsa05415 | Diabetic cardiomyopathy | 2.87E-02 | 4 | P05141, O15239, P13073, Q13557 | SLC25A5, NDUFA1, COX4I1, CAMK2D | More | |